Evidence review
UTI or Yeast Infection on a GLP-1: What to Do This Week
Symptoms now, appointment later. What the four GLP-1 labels actually say, the one question that changes the answer, and how to use a 12-minute visit.
On this page
The short version
If you have urinary or vaginal symptoms and you take a GLP-1, the fastest useful thing you can know is this: it is probably not the GLP-1, and there is one question that changes the answer — do you also take an SGLT2 inhibitor?
Everything below is the ten-minute version. Educational only, not medical advice.
The label table
I read the current prescribing information for all five products rather than working from memory. This is the whole picture on one screen:
| Product | Class | Urinary tract infection | Yeast / genital infection |
|---|---|---|---|
| Wegovy | GLP-1 | not listed in the adult table | not listed 1 |
| Ozempic | GLP-1 | not listed | not listed 2 |
| Zepbound | dual agonist | not listed | not listed 3 |
| Mounjaro | dual agonist | not listed | not listed 4 |
| Jardiance | SGLT2 | warnings for urosepsis and pyelonephritis | dedicated Warnings §5.6 5 |
Across all four GLP-1 and dual-agonist labels there is exactly one urinary tract infection entry — and it is not in an adult table. Wegovy lists urinary tract infection at 4% against 2% on placebo only in its trial of patients aged 12 and older; the adult adverse reaction table has no such row1. There are zero mentions of candidiasis, vaginal infection or genital mycotic infection anywhere in the four. The SGLT2 inhibitor has a warnings section for precisely this.
The reason is mechanical: SGLT2 inhibitors work by pushing glucose out through your urine, and yeast feeds on it. GLP-1s do not do that. There is population-based work on SGLT2 inhibitors and severe urinary tract infections in that same literature6.
The one question that changes the answer
Do you also take an SGLT2 inhibitor? The common ones end in -flozin: empagliflozin (Jardiance), dapagliflozin (Farxiga), canagliflozin (Invokana), ertugliflozin (Steglatro).
Combination therapy with a GLP-1 and an SGLT2 inhibitor is routine in type 2 diabetes. If both are in your cabinet, the genital-infection risk is real and it belongs to the other prescription. That single fact reorganizes the whole conversation, and it is the thing most likely to get missed if you only mention the drug you started most recently.
Also worth knowing regardless of medication: women with type 2 diabetes have higher rates of vaginal candida colonization and symptoms independent of any drug7. Glycemic control is part of the picture before you add anything.
The decision list
Go same-day, not next week, if: you have fever, back or flank pain, blood in your urine, vomiting, or you are pregnant. Those are the signs that a urinary infection may be moving upward, and it is not a wait-and-see situation.
Book normally if: it is burning, urgency or frequency without the above; or vaginal itching or discharge without fever. Get it tested rather than guessing — the treatments are different and a wrong guess wastes a week.
Do not assume it is the GLP-1 and stop the medication to see what happens. Nothing on the label supports that, and you will have lost your titration progress for no reason.
Do not self-treat a suspected first yeast infection over the counter if you also take an SGLT2 inhibitor and this keeps happening — recurrence is a reason for a proper workup, not a bigger box of antifungal.
Using a 12-minute appointment
The appointment is short. These are the four sentences that make it productive:
- "I take [GLP-1] and [any SGLT2 inhibitor]." Lead with both. If you take an -flozin, that is the single most relevant thing you will say.
- "This is the Nth time in M months." Recurrence changes the plan; a single episode usually does not.
- "My last A1c was X" — or "I do not know it." Either answer is useful.
- "Can we test rather than treat empirically?" Especially for a second or third episode.
If it is dryness or irritation rather than infection, that is a different conversation and the evidence in that area genuinely runs out — say "dryness, not itching or discharge," because it points somewhere else entirely. That version of the question, plus cycle changes and unexpected bleeding, is the vulvovaginal symptom map. This page is the infection one.
Where the provider you chose comes in
Two things matter here and both are provider-selection questions: whether you can get a message answered in a day when something like this comes up mid-titration, and whether the intake actually asked what else you take. A program that never asked about your other prescriptions is not in a position to help you reason about this.
See also the side-effect quick-fix reference and, for the belching version of "is this the drug", burping by drug.
Frequently asked questions
Can a GLP-1 cause a UTI or yeast infection?
Across all four GLP-1 and dual-agonist labels there is exactly one urinary tract infection entry, and it sits in Wegovy's trial of patients aged 12 and older at 4% versus 2% on placebo — the adult table has no urinary tract infection row at all. There is no mention anywhere of candidiasis, vaginal infection or genital mycotic infection. Ozempic, Zepbound and Mounjaro list none of it. The drug class with a dedicated warnings section for genital fungal infection is SGLT2 inhibitors, because they push glucose into the urine and yeast feeds on it.
How do I know if it is my other medication?
Check whether anything you take ends in -flozin: empagliflozin (Jardiance), dapagliflozin (Farxiga), canagliflozin (Invokana), ertugliflozin (Steglatro). Taking a GLP-1 and an SGLT2 inhibitor together is routine in type 2 diabetes, and if you do, the genital-infection risk in your cabinet belongs to the SGLT2 inhibitor. Mention both drugs, not just the one you started most recently.
When does a UTI need same-day care?
Fever, back or flank pain, blood in the urine, vomiting, or being pregnant. Those suggest an infection that may be moving upward and are not a wait-and-see situation. Burning, urgency or frequency without those can usually be booked normally — but get it tested rather than guessed, since the treatment differs from a yeast infection.
Should I stop my GLP-1 while I have an infection?
Nothing on the labels supports stopping for this, and doing so costs you titration progress for no clear benefit. It is a question for your clinician rather than a decision to make from an article — but going in knowing the labels do not list these infections puts you in a better position to have that conversation.
Where this leaves you
References
- U.S. Food and Drug Administration (2025). Wegovy (semaglutide) injection — Prescribing Information (no urinary tract infection in the adult adverse reaction table; 4% vs 2% appears only in the paediatric 12-and-older table; no candidiasis, vaginal or genital mycotic infection listed). DailyMed / FDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
- U.S. Food and Drug Administration (2025). Ozempic (semaglutide) injection — Prescribing Information (no urinary tract, candidiasis, vaginal or genital mycotic infection listed). DailyMed / FDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79
- U.S. Food and Drug Administration (2025). Zepbound (tirzepatide) injection — Prescribing Information (no urinary tract or genital mycotic infection listed). DailyMed / FDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b
- U.S. Food and Drug Administration (2025). Mounjaro (tirzepatide) injection — Prescribing Information (no urinary tract or genital mycotic infection listed). DailyMed / FDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0
- U.S. Food and Drug Administration (2025). Jardiance (empagliflozin) tablets — Prescribing Information, Warnings 5.6 Genital Mycotic Infections; urosepsis and pyelonephritis. DailyMed / FDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=faf3dd6a-9cd0-39c2-0d2e-232cb3f67565
- Dave CV, Schneeweiss S, Kim D, et al. (2019). Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Severe Urinary Tract Infections: A Population-Based Cohort Study. Annals of Internal Medicine. https://pubmed.ncbi.nlm.nih.gov/31357213/
- Nyirjesy P, Zhao Y, Ways K, Usiskin K. (2012). Evaluation of vulvovaginal symptoms and Candida colonization in women with type 2 diabetes mellitus treated with canagliflozin. Current Medical Research and Opinion. https://pubmed.ncbi.nlm.nih.gov/22632452/
Read this as information, not instructions. WorkingMomRx is educational and never a diagnosis, a treatment plan, or a reason to start or stop a medication. A GLP-1 is a clinical decision — run it past a licensed clinician who knows your history before you act on anything here.
Continue reading
Do You Need Pelvic Floor PT on a GLP-1?
Losing weight helps one kind of leaking and not the other. Which you have decides whether pelvic floor therapy is worth the copays — and how it's billed.
ReadDoes Ozempic Make Your Pee Smell?
Nobody has studied it, and it is not on any label. But the thing that would cause it — dehydration — is, and it has a same-day line attached. What to watch.
ReadDiarrhea on a GLP-1: The Rates, the Fixes, and the Line to Watch
Wegovy reports it in 30% of patients, Zepbound up to 23%. What the numbers mean for planning a work week, and the one symptom that changes the answer.
Read